Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 10, Issue 4, 2012, Pages 487-492

  Todaro, Barbara ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALIZAPRIDE; APREPITANT; CANNABIS; CHLORMETHINE; CHLORPROMAZINE; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOMPERIDONE; DOXORUBICIN; DRONABINOL; FOSAPREPITANT; HALOPERIDOL; LEVONANTRADOL; METOCLOPRAMIDE; MITOXANTRONE; NABILONE; PREDNISONE; PROCARBAZINE; PROCHLORPERAZINE; THIETHYLPERAZINE; VINCRISTINE;

ANXIETY DISORDER; ATAXIA; CANCER COMBINATION CHEMOTHERAPY; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CLINICAL PROTOCOL; CONFUSION; DEPRESSION; DISORIENTATION; DIZZINESS; DROWSINESS; DRUG APPROVAL; DRUG CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPHORIA; EUPHORIA; GERM CELL TUMOR; HALLUCINATION; HUMAN; HYPOTENSION; LEGAL ASPECT; LUNG CANCER; LYMPHOMA; MULTIPLE CYCLE TREATMENT; ORTHOSTATIC HYPOTENSION; OVARY CANCER; PARANOIA; POSITIONAL DIZZINESS; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; SPEECH DISORDER; TREATMENT DURATION; TREATMENT RESPONSE; XEROSTOMIA;

EID: 84860757053     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2012.0048     Document Type: Review

References (22)

1. Ettinger DS, Armstrong DK, Barbour S, et al. NCCN Clinical Practice Guidelines in Oncology for Antiemesis. Version 1, 2012. Available at: http://www.nccn.org/professionals/physician-gls/pdf/antiemesis.pdf. Accessed January 31, 2012.
2. Hesketh PJ. Chemotherapy-induced nausea and vomiting. N Engl J Med 2008;358:2482-2494.
3. Kris MG, Hesketh PJ, Somerfield MR, et al. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol 2006;24:2932-2946.
4. Roila R, Herrstedt J, Aapro M, et al. Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol 2010;21(Suppl 5):v232-243.
5. Darmani NA. Mechanism of broad-spectrum antiemetic efficacy of cannabinoids against chemotherapy-induced acute and delayed vomiting. Pharmaceuticals 2010;3:2930-2955.
6. Parker LA, Rock EM, Limebeer CL. Regulation of nausea and vomiting by cannabinoids. Br J Pharmacol 2011;163:1411-1422.
7. Tramer MR, Carroll D, Campbell FA, et al. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systemic review. BMJ 2001;323:16-21. (Pubitemid 32681999)
8. Rocha FC, Stefano SC, De Cassia Haiek R, et al. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systemic review and meta-analysis. Eur J Cancer Care (Engl) 2008;17:431-443.
9. Ahmedzai S, Carlyle DL, Calder IT, Moran F. Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy. Br J Cancer 1983;48:657-664.
10. Crawford SM, Buckman R. Nabilone and metoclopramide in the treatment of nausea and vomiting due to cisplatinum: a double blind study. Med Oncol Tumor Pharmacother 1986;3:39-42. (Pubitemid 16140301)
11. Pomeroy M, Fennelly JJ, Towers M. Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis. Cancer Chemother Pharmacol 1986;17:285-288. (Pubitemid 16070942)
12. Herman TS, Einhorn LH, Jones SE, et al. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N Engl J Med 1979;300:1295-1297. (Pubitemid 9219560)
13. Sallan S, Zinberg NE, Frei E III. Antiemetic effect of delta-9-tetrahydrocannabinoll in patients receiving cancer chemotherapy. N Engl J Med 1975;293:795-797.
14. Pacula RL, Chriqui JF, Reichmann DA, Terry-McElrath TM. State medical marijuana laws: understanding the laws and their limitations. J Public Health Policy 2002;23:413-439. (Pubitemid 36055479)
15. Controlled Substances Act. U.S. Food and Drug Administration Web site. Available at: http://www.fda.gov/RegulatoryInformation/Legislation/ucm148726. htm. Accessed January 30, 2012.
16. Okie S. Medical marijuana and the Supreme Court. N Engl J Med 2005;353:648-651. (Pubitemid 41175672)
17. Gonzalez v Raich, 545 US 1(2005).
18. Schwartz RH, Voth EA, Sheridan MJ. Marijuana to prevent nausea and vomiting in cancer patients: a survey of oncologists. South Med J 1997;90:167-172. (Pubitemid 27078730)
19. de Jong FA, Engels KF, Mathijessen RH, et al. Medical cannabis in oncology practice: still a bridge too far? J Clin Oncol 2005;23:2886-2891.
20. Joy JE, Watson SJ, Benson JA Jr, eds. Marijuana and Medicine: Assessing the Science Base. Washington, DC: National Academy Press; 1999. Available at: http://books.nap.edu/catalog/6376.html. Accessed October 6, 2011.
21. Marijuana. American Cancer Society Web site. Available at: http://www.cancer.org/treatment/treatmentsandsideeffects/ complementaryandalternativemedicine/herbsvitaminsandminerals/marijuana. Accessed October 6, 2011.
22. Seamon MJ, Fass JA, Maniscalco-Feichtl M, Abu-Shraie NA. Medical marijuana and the developing role of the pharmacist. Am J Health Syst Pharm 2007;64:1037-1045.